Hospital-level Variation in the Management of Blood Pressure and Low-density Lipoprotein in the Outpatient Hypertensives in China-a Cross Sectional Study

Fudan University logo

Fudan University

Status

Unknown

Conditions

Hypertension
Hyperlipidemia

Treatments

Other: continuing medical education program

Study type

Observational

Funder types

Other

Identifiers

NCT03862183
UPPDATE

Details and patient eligibility

About

To investigate the proportion, medication use and control rate of metabolic abnormalities such as dyslipidemia in outpatients with hypertension in different levels of hospitals in China. To investigate the gap between guidelines and clinical practices, and analyze the cause. we also set up a continuing medical education program to narrow the gap and the effect of the program will be estimated.

Enrollment

21,000 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Outpatients from departments of Cardiology, Endocrinology, Nephrology, Neurology, Geriatrics or General Internal Medicine.
  • Diagnosed as hypertension. Diagnostic criteria: 1)The office BP measured at the day of visit and at least one time before that day were above the cut-off values ( ≥140 mmHg SBP and/or ≥90 mmHg DBP); 2)for patients with normal BP at the day of visit, they should have already been given pre-treatment with antihypertensive drugs ≥ 2 weeks.
  • Voluntary participation.

Exclusion criteria

  • Patients aged< 18 years old.
  • Patients without a definite diagnosis of hypertension(for instance, if the patient has been taking antihypertensive drugs irregularly, it is difficult to confirm the diagnosis of hypertension).
  • Patients with a definite diagnosis of secondary hypertension.
  • Patients are diagnosed dyslipidemia with clear cause, such as nephrotic syndrome, severe hypothyroidism, terminal stage of malignancy, etc.
  • Patients are diagnosed end-stage renal disease, hemodialysis, and peritoneal dialysis patients.
  • Patients diagnosed with mental abnormalities who are unable to complete the questionnaire.
  • Patients have once participated in this research during this study cycle(to avoid repeated participation).

Trial design

21,000 participants in 2 patient groups

dyslipidemia in hypertension
Treatment:
Other: continuing medical education program
hypertension
Treatment:
Other: continuing medical education program

Trial contacts and locations

0

Loading...

Central trial contact

xiufang gao, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems